Your browser doesn't support javascript.
loading
Optical Coherence Tomography Advanced Parameters in Patients With Multiple Sclerosis: Ophthalmological and Neurological Assessments.
Savastano, Maria Cristina; Nociti, Viviana; Giannuzzi, Federico; Cestrone, Valentina; Carlà, Matteo Mario; Fossataro, Claudia; Biagini, Ilaria; Rizzo, Clara; Kilian, Raphael; Bisurgi, Marco; Calabresi, Paolo; Mirabella, Massimiliano; Rizzo, Stanislao.
  • Savastano MC; From the Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS (M.C.S., F.G., V.C., M.M.C., C.F., S.R.), Rome, Italy; Catholic University of the Sacred Heart (M.C.S., V.N., F.G., V.C., M.M.C., C.F., I.B., S.R.), Rome, Italy.
  • Nociti V; Catholic University of the Sacred Heart (M.C.S., V.N., F.G., V.C., M.M.C., C.F., I.B., S.R.), Rome, Italy; Centro di Ricerca Sclerosi Multipla (CERSM), Università Cattolica (V.N., M.B., M.M.), Rome, Italy.
  • Giannuzzi F; From the Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS (M.C.S., F.G., V.C., M.M.C., C.F., S.R.), Rome, Italy; Catholic University of the Sacred Heart (M.C.S., V.N., F.G., V.C., M.M.C., C.F., I.B., S.R.), Rome, Italy. Electronic address: federico.giannuzzi@gmail.com.
  • Cestrone V; From the Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS (M.C.S., F.G., V.C., M.M.C., C.F., S.R.), Rome, Italy; Catholic University of the Sacred Heart (M.C.S., V.N., F.G., V.C., M.M.C., C.F., I.B., S.R.), Rome, Italy.
  • Carlà MM; From the Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS (M.C.S., F.G., V.C., M.M.C., C.F., S.R.), Rome, Italy; Catholic University of the Sacred Heart (M.C.S., V.N., F.G., V.C., M.M.C., C.F., I.B., S.R.), Rome, Italy.
  • Fossataro C; From the Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS (M.C.S., F.G., V.C., M.M.C., C.F., S.R.), Rome, Italy; Catholic University of the Sacred Heart (M.C.S., V.N., F.G., V.C., M.M.C., C.F., I.B., S.R.), Rome, Italy.
  • Biagini I; Catholic University of the Sacred Heart (M.C.S., V.N., F.G., V.C., M.M.C., C.F., I.B., S.R.), Rome, Italy; Department NEUROFARBA, University of Florence (I.B.), Florence, Italy.
  • Rizzo C; Ophthalmology, Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa (C.R.), Pisa, Italy; Ophthalmology Unit, University of Verona (C.R., R.K.), Verona, Italy.
  • Kilian R; Ophthalmology Unit, University of Verona (C.R., R.K.), Verona, Italy.
  • Bisurgi M; Centro di Ricerca Sclerosi Multipla (CERSM), Università Cattolica (V.N., M.B., M.M.), Rome, Italy; UOC Neurologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS (M.B., P.C., M.M.), Rome, Italy.
  • Calabresi P; UOC Neurologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS (M.B., P.C., M.M.), Rome, Italy.
  • Mirabella M; Centro di Ricerca Sclerosi Multipla (CERSM), Università Cattolica (V.N., M.B., M.M.), Rome, Italy; UOC Neurologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS (M.B., P.C., M.M.), Rome, Italy.
  • Rizzo S; From the Ophthalmology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS (M.C.S., F.G., V.C., M.M.C., C.F., S.R.), Rome, Italy; Catholic University of the Sacred Heart (M.C.S., V.N., F.G., V.C., M.M.C., C.F., I.B., S.R.), Rome, Italy; Consiglio Nazionale delle Ricerche, Istituto di Neuros
Am J Ophthalmol ; 267: 41-49, 2024 Jun 18.
Article en En | MEDLINE | ID: mdl-38901720
ABSTRACT

PURPOSE:

To evaluate ophthalmological, neurological, radiological, and laboratory data in patients with multiple sclerosis (MS) and to identify new ophthalmological factors that could be helpful as biomarkers of the disease, potentially leading to an earlier prediction of disease course and disability progression.

DESIGN:

Retrospective, cross-sectional-study.

METHODS:

Best-corrected visual acuity (BCVA), ophthalmological biomicroscopy of the anterior segment and fundus, structural optical coherence tomography (OCT) with retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC), and OCT angiography (OCTA) with vascular density (VD) were performed. The following clinical and neuro-radiological features were assessed MS phenotype, disease duration, clinical severity, type of treatment, and T2-weighted lesion and T1-weighted Gd+ enhancing lesion number on the brain and spinal cord MRI.

RESULTS:

One hundred and six patients (212 eyes) were analyzed. Sixty-six of them (62.2%) had MS and 40 (37.8%) were matched healthy controls (HCs). patients with MS showed lower RNFL, GCC, and VD in the radial peripapillary capillary plexus than controls in both eyes (P < .05). By Performing a logistic regression with a distinct MS outcome for both eyes, we were able to demonstrate that the value that was most predictive of MS was the average GCC thickness (P = .009). Regression analysis demonstrated that patients with a higher T2-weighted lesions showed a lower RNFL thickness value and reduced GCC and VD values than those with a low lesion load (P < .01 and P < .05, respectively). Similarly, relapsing MS patients showed lower RNFL values (P < .05).

CONCLUSIONS:

Several OCT and OCTA-optic nerve parameters could be useful prognostic biomarkers for the MS disease course in clinical practice. However, it is necessary to do additional research with larger sample sizes in order to validate these findings.

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article